Preliminary study on the inhibitory effects of active ingredient lawsone in Chinese medicine on triple negative breast cancer
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:This stndy aims to investigate the application prospect of lawsone in the treatment of triple negative breast cancer(TNBC). Methods:Two TNBC cell lines,MDA-MB-231 and SUM1315,were selected as the research subjects. The effects of lawsone on breast cancer cells were investigated by CCK-8 assay,wound-healing assay,cellular invasion assay,colony formation assay,EdU assay and cell cycle assay. Results:The 72-hour IC50 values of MDA-MB-231 and SUM1315 were 249.87 μmol/L and 158.34 μmol/L,respectively. Lawsone could significantly inhibit the migration,invasion and proliferation of breast cancer cells,and prolong the G1 phase of breast cancer cell cycle. Conclusion:Lawsone may affect the occurrence and development of breast cancer by inhibiting the migration,invasion and proliferation of breast cancer cells.

    Reference
    Related
    Cited by
Get Citation

陆好悦,刘聪聪,肇 毅.中药活性成分散沫花素对三阴性乳腺癌细胞抑制作用的初步研究[J].南京医科大学学报(自然科学版英文版),2021,(8):1166-1172.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 13,2021
  • Revised:
  • Adopted:
  • Online: August 30,2021
  • Published:
Article QR Code